Cassava Sciences, Inc.
(NASDAQ : SAVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -0.26%93.275.5%$179.13m
VRXValeant Pharmaceuticals International, Inc. -0.86%30.0414.1%$176.76m
ICLRICON plc -0.36%204.474.2%$131.48m
CTLTCatalent, Inc. -0.40%110.552.1%$123.68m
GWPHGW Pharmaceuticals Plc 0.04%218.906.1%$117.99m
UTHRUnited Therapeutics Corp. 1.02%203.7314.1%$97.91m
JAZZJazz Pharmaceuticals Plc 0.30%168.902.3%$91.17m
BHCBausch Health Cos., Inc. -0.86%30.040.0%$90.58m
SAVACassava Sciences, Inc. -0.68%34.850.0%$53.32m
ARGXargenx SE 1.53%281.720.0%$51.68m
PRGOPerrigo Co. Plc 1.14%41.646.9%$37.87m
SAGESAGE Therapeutics, Inc. -1.14%74.647.6%$36.56m
PCRXPacira Biosciences, Inc. -4.93%63.079.9%$28.43m
AMRNAmarin Corp. Plc 0.20%5.021.5%$27.84m
ICPTIntercept Pharmaceuticals, Inc. -1.31%20.2816.8%$26.02m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.